Search review questions

Later development of cardiovascular disease · pregnant women with pre‐existing type 1 diabetes

Large‐for‐gestational age · pregnant women with pre‐existing type 1 diabetes

Severity, reduction or cessation in nausea/vomiting 2. Quality of life outcomes 3. Pregnancy complications 4. Adverse fetal/neonatal outcomes · pregnant women with hyperemesis gravidarum

Severity, reduction or cessation in nausea/vomiting 2.Days of hospital admission 3. Pregnancy complications 4. Adverse fetal/neonatal outcomes · pregnant women with hyperemesis gravidarum

Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Days of hospital admission 4. Pregnancy complications 5. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum

Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Quality of life outcomes 4. Pregnancy complications 5. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum

Days of hospital admission 2. Quality of life outcomes 3. Pregnancy complications · Pregnant women with hyperemesis gravidarum

Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Days of hospital admission 4. Intervention side effects · pregnant women with hyperemesis gravidarum

Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Quality of life outcomes · Pregnant women with hyperemesis gravidarum

Number of episodes of emesis 2. Days of hospital admission 3. Intervention side effects 4. Quality of life outcomes 5. Pregnancy complications 6. Adverse fetal/neonatal outcomes · pregnant women with hyperemesis gravidarum

Perinatal death or severe morbidity (neonatal encephalopathy, intraventricular haemorrhage, admission to intensive/high care) · pregnant women with confirmed or suspected chorioamnionitis

Low Apgar score at five minutes (less than seven or as defined by trial authors) · pregnant women with confirmed or suspected chorioamnionitis

Infant sepsis (suspected or proven) ‐ not measured · pregnant women undergoing caesarean section

Woman's perception of pain (as defined by trialists) · Pregnant women with varicose veins and leg oedema in pregnancy

Woman's perception of pain (as defined by trialists) · Pregnant women with varicose veins and leg oedema in pregnancy

Complications associated with varicose veins and leg oedema (venous leg ulcer) · Pregnant women with varicose veins and leg oedema in pregnancy

Symptoms associated with varicose veins and oedema · Pregnant women with varicose veins and leg oedema in pregnancy

Perinatal death and or severe morbidity (neonatal intensive care unit admission, neonatal encephalopathy) · Pregnant women who had reached the gestational age of fetal viability

Small‐for‐gestational age · Women with a multiple pregnancy for improving maternal and infant outcomes

Very preterm birth (defined as birth less than 34 weeks' gestation) · Women with a multiple pregnancy for improving maternal and infant outcomes

Rate of congenital toxoplasmosis defined by persistence of IgG antibodies beyond 11 months · women of reproductive age, irrespective of their pregnant status

Pregnant women knowledge of risk factors for acquiring toxoplasmosis infection as objectively measured through specific questionnaire · women of reproductive age, irrespective of their pregnant status

Pregnant women awareness of the importance of avoiding toxoplasmosis infection during pregnancy as objectively measured through specific questionnaire · women of reproductive age, irrespective of their pregnant status

Low birthweight · Pregnant women recruited before 20 weeks' gestation

Perinatal mortality rate · Pregnant women recruited before 20 weeks' gestation

Sudden infant death syndrome · Pregnant women recruited before 20 weeks' gestation

Gestational diabetes · Pregnant women recruited before 20 weeks' gestation

Mean GWG (kg) · pregnant women

Admission to neonatal special care unit or intensive care unit · Pregnant women with/without complications

Neurodevelopmental disability at 12 months of age · Pregnant women with/without complications

Caesarean section for non‐reassuring or abnormal fetal heart rate patterns · Pregnant women with/without complications

Women's satisfaction with care · Pregnant women with/without complications

Neurodevelopmental disability at 12 months of age · Pregnant women with/without complications

Caesarean section for non‐reassuring or abnormal fetal heart rate patterns · Pregnant women with/without complications

Women's satisfaction with care · Pregnant women with/without complications

Neonatal detection of large‐for‐gestational age · Pregnant women with singleton fetuses who were of 20 weeks' gestation and above.

Intrauterine death · Pregnant women with singleton fetuses who were of 20 weeks' gestation and above.

Neurodevelopmental outcome in childhood · Pregnant women with singleton fetuses who were of 20 weeks' gestation and above.

Maternal mortality ‐ not reported · women with postpartum iron deficiency anaemia

Fatigue ‐ not reported · women with postpartum iron deficiency anaemia

Constipation ‐ not reported · women with postpartum iron deficiency anaemia

Maternal mortality · women with postpartum iron deficiency anaemia

Fatigue ‐ not reported · women with postpartum iron deficiency anaemia

Infections ‐ not reported · women with postpartum iron deficiency anaemia

Maternal mortality · women with postpartum iron deficiency anaemia

Fatigue ‐ not reported · women with postpartum iron deficiency anaemia

Thromboembolic events ‐ not reported · women with postpartum iron deficiency anaemia

Persistent anaemia symptoms ‐ not reported · women with postpartum iron deficiency anaemia

Persistent anaemia symptoms ‐ not reported · women with postpartum iron deficiency anaemia

Maternal mortality ‐ not reported · patients with women with postpartum iron deficiency anaemia